Exyte
↗Stuttgart, Germany
Exyte is a global leader in the design, engineering, and delivery of ultra-clean and sustainable facilities for high-tech industries. Founded in 1912, the company has evolved from a ventilation specialist into a premier provider of Engineering, Procurement, and Construction (EPC) and Engineering, Procurement, and Construction Management (EPCM) services for the semiconductor, battery, and life sciences sectors.
In the pharmaceutical and biotechnology markets, Exyte specializes in the creation of complex, GMP-compliant manufacturing environments. Following its strategic acquisition and integration of Pharmaplan and TTP Group in 2024-2025, the company has significantly expanded its European footprint and technical expertise in biopharma process engineering. Exyte is a key enabler for the production of advanced therapies, including cell and gene therapies, mRNA vaccines, and biologics, utilizing proprietary digital tools like 'ExyVision' for digital twin modeling and facility optimization.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:High-tech facility engineering and construction
SIZE & FINANCIALS
Employees:5001-10000
Revenue:€7.1B
Founded:1912
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Investors:Stumpf Group, ACMH, Jenoptik, Springwater Capital, VICTORY Industriebeteiligung
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Service Provider)
Modalities:Biologics, Cell therapy, Gene therapy, RNA, Small molecule, Vaccines, Radiopharmaceuticals, ATMPs
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Stumpf Group
Acquired By:Stumpf Group (2009-01-01)
Subsidiaries:Pharmaplan, Kinetics, Exentec, CollabraTech Solutions, Airgard, Intega, Exyte Hargreaves
Key Partnerships:JGC Corporation (Nixyte Joint Venture for high-tech infrastructure), Syntegon (Pharma manufacturing showroom collaboration), AES Cleanroom Technology (Modular cleanroom partnership), CATL (Facility Diamond Partner for battery gigafactories)
COMPETITION
Position:Leader
Competitors:Black & Veatch, Bechtel, Fluor, Jacobs, Lindner SE, Azbil Corporation, AES Clean Technology
LEADERSHIP
Key Executives:
Dr. Wolfgang Büchele - Chairman and CEO
Peter Schönhofer - CFO
Ronan Donohue - President, Global Business Unit Biopharma and Life Sciences
Scientific Founders:Karl Meissner (Co-founder), Paul Wurst (Co-founder)
Board Members:Georg Stumpf (Chairman of the Supervisory Board)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Exyte. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.